TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
42 hedge funds and large institutions have $101M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
67% less call options, than puts
Call options by funds: $152K | Put options by funds: $464K
Holders
42
Holding in Top 10
2
Calls
$152K
Puts
$464K
Top Buyers
| 1 | +$3.14M | |
| 2 | +$2.09M | |
| 3 | +$1.16M | |
| 4 |
Renaissance Technologies
New York
|
+$588K |
| 5 |
Two Sigma Investments
New York
|
+$536K |
Top Sellers
| 1 | -$1.3M | |
| 2 | -$878K | |
| 3 | -$800K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$492K |
| 5 |
Goldman Sachs
New York
|
-$246K |